Source:http://linkedlifedata.com/resource/pubmed/id/17894651
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
8
|
| pubmed:dateCreated |
2007-9-26
|
| pubmed:abstractText |
A better understanding of predictors of risk for pancreatic ductal adenocarcinoma (PDAC) could inform preventive efforts against this lethal cancer. While aspirin (ASA) and non-steroidal anti-inflammatory drugs (NSAIDS) might protect against several gastrointestinal cancers, their role in the development of PDAC remains unclear.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0269-2813
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
26
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1089-99
|
| pubmed:meshHeading |
pubmed-meshheading:17894651-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:17894651-Carcinoma, Pancreatic Ductal,
pubmed-meshheading:17894651-Dose-Response Relationship, Drug,
pubmed-meshheading:17894651-Female,
pubmed-meshheading:17894651-Humans,
pubmed-meshheading:17894651-Male,
pubmed-meshheading:17894651-Outcome Assessment (Health Care),
pubmed-meshheading:17894651-Pancreatic Neoplasms,
pubmed-meshheading:17894651-Risk Factors
|
| pubmed:year |
2007
|
| pubmed:articleTitle |
Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories.
|
| pubmed:affiliation |
Digestive and Liver Disease Unit, II Medical School, University La Sapienza, Rome, Italy.
|
| pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|